Patients in II stage, patients with tumor diameter ≥3 cm, and patients with lymph node metastasis trended to have higher positive rate of anti‐Hp antibody and higher serum levels of CA724, CA19‐9, and CEA. Here, HP is linked to metastatic malignant neoplasm in the lymph nodes.